Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Guokang Pharmaceutical is a Chinese pharmaceutical manufacturer based in Harbin, Heilongjiang Province, specializing in the production of chemical drugs and traditional Chinese medicine preparations. The company is a key subsidiary of the Harbin Pharmaceutical Group (Hayao) and focuses heavily on treatments for cardiovascular and cerebrovascular conditions. Its flagship products include Alprostadil injections, which are widely used for peripheral vascular diseases and microcirculation disorders. Harbin Guokang operates multiple GMP-certified production lines for small-volume injections, tablets, and capsules. The firm plays a significant role in the domestic Chinese market by providing essential generic medicines and specialized biochemical treatments. Its operations are integrated into the broader supply chain of one of China's largest pharmaceutical conglomerates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Guokang Pharmaceutical.